biotech / news / / Devdiscourse
Sun Pharmaceutical Industries Ltd has declared its acquisition of US-based healthcare company Organon & Co in an all-cash deal worth USD 11.75 billion.
Sun Pharma is acquiring US-based Organon & Co for USD 11.75 billion in cash.
KEY POINTS
- The acquisition is valued at USD 14 per Organon share.
- Sun Pharma's shares surged over 7 percent following the acquisition announcement.
- This deal strengthens Sun Pharma's presence in women's health and biosimilars.
COMPANIES
Summarized by Newsio from Devdiscourse. How we summarize →